OTC Markets OTCQB - Delayed Quote USD
Qrons Inc. (QRON)
0.0951
0.0000
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Cory J. Rosenberg | Chairman, CEO, President, Acting Chief Financial Officer & Secretary | 150k | -- | 1981 |
| Mr. Chris L. Claussen | Chief Innovation Officer & Director | -- | -- | 1970 |
| Mr. Chris Claussen | Executive Director | -- | -- | -- |
| Mr. Robert C. Kaelin | Head of Mycology & Psychedelics | -- | -- | 1975 |
Qrons Inc.
444 – 5th Avenue SW
Suite 1840
Calgary, AB T2P 2T8
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 10
Description
First Person Ltd., through its subsidiaries, engages in the formulation and distribution of wholesale food grade functional mushrooms and cognitive performance products focusing on the mental performance and wellness markets in the United States. It focuses on the research and development of psilocybin mushrooms. The company is headquartered in Calgary, Canada.
Corporate Governance
Qrons Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
February 6, 2025 at 12:00 AM UTC
SC 14F1: Statement regarding change in majority of directors pursuant to Rule 14f-1